Analysts at William Blair lowered their Q1 2025 earnings estimates for Legend Biotech in a research report issued to clients ...

Fintel reports that on March 17, 2025, William Blair upgraded their outlook for DocuSign (NasdaqGS:DOCU) from Market Perform ...

Incyte's skin disease treatment looks "viable, but not competitive with biologics," an analyst said Monday as Incyte stock fell.

We recently published a list of 11 Best Reddit Stocks to Invest In. In this article, we are going to take a look at where ...

Software company DocuSign (DOCU) scored a rating upgrade from Hold to Buy from William Blair, thanks to the optimism about ...

A Wall Street analyst believes Palantir's (NASDAQ: PLTR) expanding artificial intelligence (AI) ecosystem, marked by major ...

William Blair analyst Louie DiPalma maintained a Hold rating on Science Applications (SAIC – Research Report) today. The company’s shares ...

Portugal has announced that it will not go ahead with the purchase of Lockheed Martin F-35 aircraft. Canada is also looking for alternatives to the powerful ...

When accused by King of dodging the question, Isaacs was clear that, yeah, he was, because he perceives a major double ...

Chiefs Coach and BYU grad Andy Reid was on hand to watch the Cougars fall behind 15-0. At halftime, the Houston lead was ...

Baer also told analysts that Stitch Fix customers span all income levels, and that most U.S. shoppers are unhappy with the current in-store shopping experience for clothing. The executive cited market ...

The pain will steadily subside this year, however, as the footwear brand makes progress toward a more profitable distribution ...